|Articles|November 1, 2003
Slow, Steady Tx Release
Author(s)Louise Gagnon
San Diego - The most current data from an open label trial show that hydroquinone 4 percent with retinol is an effective and safe option to treat melasma and post-inflammatory hyperpigmentation, according to Pearl Grimes, M.D., the study's principal investigator.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
New Consensus Defines Remission, Disease Activity in Atopic Dermatitis
2
Switching from Biologics to Upadacitinib Yields Progressive Improvements in Moderate to Severe AD
3
Systemic JAK Inhibitors for Vitiligo: Emerging Clinical Trial Data and Safety Considerations
4
Beyond Retinol: Evaluating the Stability, Safety, and Gene-Expression Profile of Bakuchiol Ferulate
5








